The authors examined whether early ultrasound dating (≤20 weeks) of gestational age (GA) in small-forgestational-age (SGA) fetuses may underestimate gestational duration and therefore the incidence of SGA birth. Within a population-based case-control study (May 2002-June 2005 of Iowa SGA births and preterm deliveries identified from birth records (n = 2,709), the authors illustrate a novel methodological approach with which to assess and correct for systematic underestimation of GA by early ultrasound in women with suspected SGA fetuses. After restricting the analysis to subjects with first-trimester prenatal care, a nonmissing date of the last menstrual period (LMP), and early ultrasound (n = 1,135), SGA subjects' ultrasound GA was 5.5 days less than their LMP GA, on average. Multivariable linear regression was conducted to determine the extent to which ultrasound GA predicted LMP dating and to correct for systematic misclassification that results after applying standard guidelines to adjudicate differences in these measures. In the unadjusted model, SGA subjects required a correction of +1.5 weeks to the ultrasound estimate. With adjustment for maternal age, smoking, and first-trimester vaginal bleeding, standard guidelines for adjudicating differences in ultrasound and LMP dating underestimated SGA birth by 12.9% and overestimated preterm delivery by 8.7%. This methodological approach can be applied by researchers using different study populations in similar research contexts. bias (epidemiology); gestational age; infant, small for gestational age; pregnancy; premature birth; ultrasonography Abbreviations: ACOG, American College of Obstetricians and Gynecologists; GA, gestational age; IHIPS, Iowa Health in Pregnancy Study; LMP, last menstrual period; LMP ga , last menstrual period gestational age; PTD, preterm delivery; SGA, small-for-gestational-age; US ga , ultrasound gestational age.
Accurate gestational age (GA) dating of pregnancies is vital to public health surveillance and research investigating the causes of small-for-gestational-age (SGA) birth and preterm delivery (PTD). Errors in estimating GA can result in misclassification, limiting progress towards identifying vulnerable times of fetal exposure and strategies to prevent adverse pregnancy outcomes.
The most widely available approaches for estimating the duration of gestation are last menstrual period (LMP) dating (i.e., based on a woman's self-reported date of the LMP before conception) and early ultrasound dating (≤20 weeks). The shortcomings of LMP dating include inaccurate recall, the assumption that all menstrual cycles last 28 days, and the possibility of mistaking vaginal bleeding early in pregnancy as a menstrual period (1) (2) (3) . For these reasons, ultrasound dating at or before 20 weeks' gestation tends to be more accurate than LMP dating, particularly when performed in the first trimester. On the other hand, fetal ultrasound dating assumes that fetal growth is relatively uniform early in gestation (4, 5) ; this assumption may not be true, however, particularly in the growth-restricted fetus (6, 7) .
Although early ultrasound dating among women with normally grown fetuses has been shown to be more accurate than LMP dating (8) (9) (10) , a small body of research suggests that reliance on first-or second-trimester ultrasound dating of SGA fetuses is more likely to underestimate GA than a reliable date of LMP reported during the first trimester of prenatal care (9, (11) (12) (13) . Findings from a large randomized clinical trial of early ultrasound dating among women with regular menstrual cycles and a reliable LMP support this hypothesis, showing that ultrasound tended to systematically underestimate GA among women prospectively diagnosed with SGA infants (14) . Reliance on ultrasound dating alone led to an artificially low reported rate of SGA birth and an artificially high rate of PTD (14, 15) . In a study of pregnancies conceived by in vitro fertilization (i.e., with an accurate date of conception), fetuses dated as being 5 or 6 days younger by ultrasound at 10-14 weeks' gestation were substantially more likely to be SGA at delivery (13) .
The serial ultrasound studies used to establish GA standards were typically restricted to low-risk women with regular menstrual cycles of approximately 28 days and reliable LMP dates (15) . These measurement standards are less likely to be accurate when applied to the high-risk obstetric populations typically recruited for case-control studies.
To date, very few studies have assessed the validity of ultrasound dating among women with SGA babies, and no methods have been developed to correct for potential ultrasound dating bias in this subpopulation. Therefore, in the following case-study example, we illustrate a novel methodological approach specifically developed to assess and correct for the systematic underestimation of GA by early ultrasound dating among infants suspected to be SGA identified from livebirth records.
THE IOWA HEALTH IN PREGNANCY STUDY
We developed the approach and methods using data from the Iowa Health in Pregnancy Study (IHIPS), a populationbased case-control study designed to determine the influence of intimate partner violence and maternal stress on the risks of preterm and SGA outcomes among livebirths to residents of 4 Iowa counties during the period May 2002 through June 2005. Using electronic birth certificates as the sampling frame, we selected all Iowa residents of the study counties who delivered a singleton preterm infant (<37 weeks) based on the LMP or the clinical estimate of GA, or who delivered an SGA infant in the lowest 10th percentile of birth weight for GA at delivery using a nomogram derived from 1994-1996 US births (16) , for recruitment into the study. Control subjects, defined as women who delivered normally grown or full-term singleton infants, were randomly selected after frequency-matching on county of residence among cases. Excluded from the study were women under 18 years of age at the time of delivery, those with multiple births, non-English speakers, and women with preexisting type 1 or type 2 diabetes mellitus, systemic lupus, or chronic renal disease. If a participant had more than 1 livebirth during the study period, only data on the first qualifying delivery were included. All protocols and informed consent procedures were approved by the University of Iowa Biomedical Institutional Review Board.
Participation in the IHIPS consisted of a brief eligibility screening, a 45-minute computer-assisted telephone interview covering demographic factors, lifestyle characteristics, and medical and pregnancy history, and provision of a signed medical record release allowing the research team to review subjects' prenatal and hospital delivery records. Trained medical record abstractors reviewed prenatal and hospital delivery records to document reproductive history, LMP, estimated GA based on the earliest ultrasound examination, the dates and content of prenatal care, vaginal bleeding, and antepartum smoking. Of 7,202 potential subjects selected from livebirth records, 4,250 (59.0%) were reached by phone. Of these, 19.7% (n = 836) refused to participate and 12.9% (n = 548) were ineligible. Of the 2,866 women eligible to participate, nearly 95% (n = 2,709) completed the computer-assisted telephone interview. The overall response rate, defined as the proportion of women who consented to screening for the study out of all those who were selected from the birth certificates, was 45.2%. The participation rate, defined as the proportion of women who consented to screening for the study out of those who were successfully contacted by study staff, was 76.6% (17) . Signed medical record releases were received from over 90% of interviewed subjects, and medical chart abstractions were completed for 93.5% (n = 2,308) of medical releases received.
ANALYTICAL APPROACH

Restricting the analysis sample
To determine whether early ultrasound dating of GA tends to underestimate the duration of gestation among women with suspected SGA infants based on livebirth certificate data, we restricted the analysis to IHIPS case and control subjects who had complete data from computer-assisted telephone interviewing and medical chart abstraction and who met each of the following criteria: 1) first-trimester prenatal care, 2) a nonmissing LMP date, and 3) a first recorded ultrasound examination taken between the 7th and 20th completed weeks of pregnancy. Because early prenatal care is associated with better recall of LMP and access to early ultrasound, all included subjects had to initiate prenatal care before the 14th completed gestational week. If the LMP date was missing from the medical chart, it was substituted from the birth certificate. Because the ultrasound measurement site (e.g., biparietal diameter or gestational sac) was not abstracted, subjects imaged before 7 completed weeks of gestation were excluded to increase the likelihood that the ultrasound measurement was based on more precise biometric measurements (18) .
A total of 1,135 of the 2,709 interviewed subjects (41.8%) met inclusion criteria. Based on their livebirth certificate data (hereafter referred to as initial status), 493 subjects had an initial status of SGA birth, 256 were classified as PTD, and 386 were selected as controls. All data analysis was conducted using SAS software, version 9.2 (SAS Institute Inc., Cary, North Carolina). computation. A positive days difference (i.e., >0) indicates that the LMP dated the fetus as older, or more mature, than the corresponding ultrasound estimate; a negative days difference (i.e., <0) indicates that the LMP dated the fetus as younger, or less mature, than the ultrasound estimate. Thus, if ultrasound tends to underestimate GA among women with suspected SGA, we would expect to see a positive days difference with reference to the LMP estimate of GA.
Within each of the 3 categories of subjects (SGA, PTD, and controls), we analyzed the days difference variable using measures of central tendency (mean, median, standard deviation) and displayed these findings in graphical form for clarity of interpretation. Student's t test was used to compare the mean days differences by initial case-control status.
The mean days differences for PTD and control subjects were similar: 1.1 days and -0.2 days, respectively. In contrast, the mean days difference for SGA subjects was 5.5 days, which is substantially higher than the days difference observed among control (P < 0.0001) and PTD subjects, and is supportive of the hypothesis that ultrasound dating tends to underestimate GA among women with suspected SGA (see Web Figure 1 , which appears on the Journal's website (http://aje.oxfordjournals.org/)). Because the days differences among control and PTD subjects were similar, these 2 groups were combined in further analyses.
Applying standard guidelines to adjudicate differences between LMP and ultrasound estimates of GA We applied the guidelines of the American College of Obstetricians and Gynecologists (ACOG) to identify subjects with substantial differences between LMP and ultrasound dating and to determine when the ultrasound estimate should be substituted for the LMP estimate. For women with ultrasonography performed before 14 completed weeks of gestation, ACOG recommends use of the ultrasound estimate of GA when the two estimates (i.e., the days difference) disagree by more than 7 days (±7 days). For ultrasonography performed between 14 weeks and 20 weeks, ACOG recommends use of ultrasound dating when the days difference exceeds 10 days (±10 days) (19) . If the days difference is within the ACOG bounds described above, adequate agreement between the two measures is assumed, and the LMP estimate of GA is used.
Using the days difference variable, we created a new variable to signify instances in which the GA reassignment from LMP to ultrasound dating results in an older or younger estimate of GA. Figure 1 provides a graphical depiction of the direction and extent of dating differences between the LMP and ultrasound GA among control/PTD and SGA subjects following application of the ACOG guidelines. Agreement between the two dating methods according to the ACOG guidelines was nearly 80% (n = 512) among control/PTD subjects and 68.4% (n = 337) in SGAselected subjects. By definition, these subjects did not require replacement of LMP dating with ultrasound. Among the control/PTD subjects requiring reassignment of LMP GA to ultrasound dating (n = 130), 56.1% (n = 73) had an LMP GA greater than the ultrasound GA; 43.8% (n = 57) had an LMP GA less than that of the ultrasound GA. In contrast, of the 156 SGA subjects with LMP dating replaced by ultrasound, 87.2% (n = 136) were reassigned to an ultrasound GA that dated the fetus as being younger or less mature. Furthermore, the distribution of days differences in the SGA group was heavily weighted towards a positive days difference regardless of when the ultrasound was performed (data not shown), suggesting a uniform and systematic bias of ultrasound to underestimate gestational length in women with presumed SGA infants.
Identifying maternal and pregnancy characteristics associated with GA dating discrepancies
To identify factors that might be associated with differences between LMP and ultrasound dating, and therefore the likelihood that ultrasound dating would replace LMP dating per the ACOG guidelines, we examined selected maternal characteristics and their association with the likelihood that ultrasound dating would replace LMP dating within the 2 groups of subjects (i.e., control/PTD and SGA). The characteristics examined included: maternal age, race, ethnicity, education, individual and household income, smoking during the first or second trimester, periconceptional and prenatal vitamin use, first-trimester vaginal bleeding, and intention to become pregnant.
Among the SGA-selected subjects, several maternal characteristics were associated with LMP reassignment to ultrasound dating, whereas there were few such associations among the control/PTD women (Table 1) . SGA subjects were more likely to be reassigned from LMP to ultrasound dating if they were young, smoked during the first or second trimester, had low educational attainment, or had low reported income. Among control and PTD subjects, use of prenatal vitamins was the only variable associated with reassignment.
Approach for estimating a GA correction factor
As the next step, we conducted multivariable linear regression modeling to determine the extent to which ultrasound GA dating predicts LMP dating by comparing the slope and parameter estimates derived from unadjusted and adjusted models stratified according to the 2 subject groups. As expected, adjustment was indicated for SGA-selected subjects but not for the control/PTD group. Variables tested for interaction with ultrasound GA were selected on the basis of their a priori potential to influence the timing of early ultrasound (i.e., maternal age, first-trimester vaginal bleeding, periconceptional and prenatal use of multivitamins, first-or second-trimester smoking). In the absence of interaction, a main-effects model would be considered. Covariates were retained in the prediction models if the chi-squared P value for the beta coefficient was less than 0.10.
In our approach to correct for the systematic error in ultrasound dating of SGA subjects, we constructed 5 multivariate linear regression models examining the relation between LMP GA (the dependent variable) and ultrasound (US) GA (the independent variable). In the simple linear regression model (i.e., LMP ga = B 0 + B 1 US ga ), the 95% confidence interval for the ultrasound beta coefficient (B 1 ) did not include 1, reinforcing our interpretation of previous analyses that systematic bias was likely to be present. Therefore, a correction to the ultrasound estimate of GA among women with an initial status of SGA was indicated. Maternal characteristics that significantly contributed to the relation between LMP and ultrasound GA among SGA-selected subjects were maternal age, smoking during the first or second trimester, and first-trimester vaginal bleeding.
To calculate the ultrasound correction factor, we used the intercept value (B 0 ) from the multivariate linear regression models as the initial GA correction value added to (or subtracted from) the ultrasound estimate of GA. If interaction was present in the model, the difference in the slope (m) of each level of the interacting variable and the value of 1 was multiplied by the original ultrasound estimate of GA (US ga ).
Slope correction ¼ ð1 À mÞ Â US ga :
Next, the parameter estimates (B 1 − B 6 ) for the individual levels of the main-effect variables were added to or subtracted from the intercept value (B 0 ).
The parameter correction and slope correction values were then summed to determine the ultrasound GA correction factor.
Parameter correction þðð1 À mÞ Â US ga ÞÞ |fflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflffl}
Slope correction : Table 2 shows the ultrasound correction factors estimated from the multivariate linear regression models. On average, simple linear regression (i.e., LMP ga = B 0 + B 1 US ga ) estimated an ultrasound GA correction factor of 1.5 weeks (data not shown). Regardless of the multivariable linear regression model used, the ultrasound GA correction factor decreased as the subject's age increased. To illustrate how the ultrasound correction factor is estimated, we provide an example in Table 3 using model 2a for one of the 3 maternal age strata (25-29 years). The correction factors for smokers and nonsmokers calculated in our example from model 2a in Table 3 directly correspond with those displayed in Table 2 under model 2a for women aged 25-29 years.
Selecting an appropriate multivariable linear regression model
To identify the multivariable linear regression model that best fit the data and should be applied to the data set, we used the likelihood ratio test. The likelihood ratio test compares a full model with reduced models to determine the model with the best statistical fit to the data (20) .
The relation between LMP and ultrasound dating was best explained by model 4 ( Table 2 ). The likelihood ratio tests for model 2 (P = 0.005) and model 4 (P = 0.001) were significantly different from the main-effects model. Although model 3 explained a large amount of the variance in the data, it was not significantly different from the main- effects model (P = 0.22). Given that model 4 provided the best fit, we applied it to the data set.
Determining final birth outcome classifications
The initial birth outcome classifications of IHIPS subjects based on birth certificate data were compared with the birth outcomes derived from each of the 5 multivariate linear regression models containing the ultrasound dating correction factor. For each model, the corrected ultrasound estimate was used to calculate a corrected ultrasound estimate of GA at delivery. The LMP GA at delivery was assigned as the final estimate of GA unless the LMP differed from the corrected ultrasound estimate by ACOG guidelines; when different, the corrected ultrasound estimate of GA at delivery was assigned. The final GA estimate was used to determine a subject's final classification as either preterm, SGA, or control. Table 4 shows the cross-tabulation of all subjects according to initial case-control classification based on birth certificate data alone versus the final case-control classification obtained by applying the ACOG guidelines without ultrasound GA correction and with correction by multivariate linear regression modeling incorporating the correction factors. Application of the ACOG guidelines without correction yielded 532 controls, 287 PTD cases, 276 SGA cases, and 40 PTD/SGA cases. In contrast, each of the multivariate linear models yielded fewer controls and PTD c LMP ga at time of ultrasound = B 0 + US ga + first-or second-trimester smoking + first-trimester vaginal bleeding + age at delivery (LRT = −891.76; referent model for comparison with models 2-4).
d LMP ga at time of ultrasound = B 0 + US ga + first-or second-trimester smoking + first-trimester vaginal bleeding + age at delivery + US ga × firstor second-trimester smoking (LRT = −886.46, P = 0.005).
e LMP ga at time of ultrasound = B 0 + US ga + first-or second-trimester smoking + age at delivery + US ga × first-or second-trimester smoking (LRT = −886.47; P = 0.001 in comparison with the main-effects model of smoking and age at delivery (LRT = −891.76)).
f LMP ga at time of ultrasound = B 0 + US ga + first-or second-trimester smoking + first-trimester vaginal bleeding + age at delivery + US ga × firsttrimester vaginal bleeding (LRT = −890.26, P = 0.223).
g LMP ga at time of ultrasound = B 0 + US ga + first-or second-trimester smoking + first-trimester vaginal bleeding + age at delivery + US ga × firsttrimester vaginal bleeding + US ga × first-or second-trimester smoking (LRT = −884.73, P = 0.001).
Correction of Ultrasound GA Dating 451
Am J Epidemiol. 2012;176(5):443-455 cases and more SGA subjects. Notably, models 2, 2a, 3, and 4 yielded very similar outcome classifications. Relative to outcomes obtained by applying the ACOG guidelines without correction, model 4 yielded 8.7% fewer PTD cases and 12.9% more SGA cases.
CONCLUSIONS AND LESSONS LEARNED
Through this case-study example, we have demonstrated a new analytic approach with which to assess, model, and adjust for systematic bias resulting from the tendency of early ultrasound to underestimate GA in SGA and growthrestricted fetuses. We applied this approach in the context of a case-control study that was specifically designed to assess SGA and PTD outcomes-a retrospective study design and setting that is the most vulnerable to such bias.
As hypothesized, suspected SGA fetuses were systematically dated as being younger or less mature by ultrasound than by an LMP date reported in the first 13 weeks of pregnancy; this resulted in an overestimation of PTD cases and an underestimation of SGA cases. After applying the ACOG guidelines for adjudicating differences between these two sources of dating, nearly 90% of subjects initially identified as SGA (based on birth certificate data) and whose LMP dating was replaced with the ultrasound estimate were dated younger by ultrasound; on average, these subjects required a correction of +1.5 weeks based on the unadjusted linear regression model. After applying an ultrasound dating correction factor in the final adjusted model, the number of SGA cases increased by 12.9% and the number of PTD cases decreased by 8.7%. These results are consistent with findings reported in the handful of prior studies where investigators have questioned the accuracy of early ultrasound dating in SGA fetuses (13, 14) ; it also makes biologic sense, because SGA fetuses are physically small and ultrasound estimates are based on fetal size. Some authors have even suggested that secular increases in PTD rates and concomitant decreases in rates of SGA birth in the United States may largely be a consequence of increased reliance on ultrasound dating in recent decades (21) .
Across all models examined, we consistently observed that the ultrasound dating correction factor decreased as maternal age increased. This association is not unexpected, because older maternal age at conception is a major indication for earlier ultrasound. Furthermore, older women may be more likely to plan a pregnancy and therefore may have a more certain LMP date, resulting in closer agreement between dating methods (5, 22) . As in previous research, our findings demonstrate higher agreement between LMP and ultrasound dating among women reporting higher education and planned pregnancies (5, 8, 23) .
Importantly, the specific ultrasound GA dating correction factors estimated from multivariate linear regression modeling may vary according to the specific characteristics of the case-control study population (e.g., smoking habits, maternal age, race/ethnicity) to which this method is applied, the size of the study population, and the frequency distribution of SGA and PTD in the study sample. Therefore, we caution researchers that the specific correction factors derived using our particular study population should not be applied directly to their populations. Instead, we encourage other researchers to apply the methodological approach illustrated in this case-study example to their own study populations in order to derive their own final model and correction factors. Whereas most epidemiologic studies or large administrative data sets examining SGA and PTD outcomes will have data on maternal age and smoking, which were included in our final model, they may not have information on vaginal bleeding during the first trimester. By design, the IHIPS specifically collected data on vaginal bleeding in early pregnancy because accurate gestational dating was needed in order to optimize our ability to correctly classify the study outcomes. Although vaginal bleeding was a significant statistical predictor of LMP GA, inclusion of vaginal bleeding in the final model made no difference in the number of subjects who were ultimately classified as SGA or PTD because of the small number of women who reported vaginal bleeding in our analysis data set. Validation of our final correction factors through bootstrapping, an approach using "resampled data to make adjustments for statistical bias as well as for random error" (20, pp. 428-429) , in the IHIPS data set or in a different case-control study sample with high proportions of SGA birth and PTD is an important next step to pursue in a future analysis.
Our analysis was subject to some limitations. The certainty of a woman's LMP date and menstrual cycle length was not ascertained. Menstrual cycles sometimes vary from the 28-32 days used in pregnancy dating assumptions and often have a later time of ovulation (24) . A longer cycle could account for a positive days difference between LMP and ultrasound dating; however, this is unlikely to account for the results found here, because this association was observed only in the SGA-selected subjects. Furthermore, there is no reason to believe that subjects selected as controls or PTD subjects would have shorter cycles than SGAselected subjects. Case-control study designs are subject to recall bias. Although SGA-selected subjects were more likely to report smoking than control/preterm subjects, given that smoking is a fundamental cause of fetal growth restriction, these differences are more likely to be due to the disease process itself and not to recall bias. Furthermore, ultrasound and LMP estimates of GA were obtained from the subjects' prenatal and delivery medical records and therefore were collected before the pregnancy outcome was known, minimizing vulnerability to bias. Finally, while infant health outcomes were not examined in this analysis, this will be another important next step towards validating this new method.
This case-study example illustrates a novel analytical approach with which to estimate and correct for ultrasound misclassification of GA in infants with suspected fetal growth restriction. Our findings provide strong evidence indicating that sole reliance on early ultrasound dating (i.e., before 21 weeks) among infants with suspected fetal growth restriction based on birth certificate data alone increases the likelihood of undercounting SGA outcomes and of overcounting PTD outcomes.
